Company Profile
|
XTL Biopharmaceuticals Ltd.
(NASDAQ: XTLB)
|
5:30 PM UTC, 07/03/24 | |||
|---|---|---|---|---|
| Last: $2.30 | Change: +0.03 | %Change: +1.32% | Volume: 7,218 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 2.26 | Volume: | 7,218 | |
|---|---|---|---|---|
| High: | $ 2.30 | Yield(%) | 0.00 | |
| Low: | $ 2.21 | P/E Ratio (ttm): | n/a | |
| Dividend ($): | n/a | Market Cap ($): | 12.37M | |
| EPS ($) | -0.07 | Shares Out: | 5.45M |
| % Price Change (last 4 weeks): | -9.92 |
|---|---|
| % Price Change (last 13 weeks): | -19.50 |
| % Price Change (last 26 weeks): | 132.25 |
| % Price Change (last 52 weeks): | 127.00 |
| % Price Change (year to date): | 124.73 |
| Return on Equity (%): | -57.31 |
|---|---|
| Return on Assets (%): | -53.90 |
| Return on Invested Capital (%): | -21.62 |
| Gross Profit Margin (%): | n/a |
|---|---|
| Net Profit Margin (%): | n/a |
| Operating Profit Margin (%): | 0.00 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $2.46 |
|---|---|
| 200-day Moving Average: | $1.38 |
| Avg. Daily Vol. (last 50 days): | 17,726 |
| Avg. Daily Vol. (last 200 days): | 241,528 |
| 52-wk high: | $4.99 |
| 52-wk low: | $0.75 |
| Bid: | $2.10 |
| Ask: | $2.30 |
|
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
|
|
XTL Biopharmaceuticals Ltd.
26 Ben-Gurion Street Ramat Gan TA 5112001 Phone: 972.3.611.6600 Fax: n/a http://www.xtlbio.com |
| Earnings (1year) ($): | -0.07 |
|---|---|
| Annual Dividend ($): | 0.00 |
| Current P/E Ratio (ttm): | n/a |
| Book Value ($): | 0.41 |
| Cash Flow ($): | -0.33 |
| Price/Earnings (x): | n/a |
|---|---|
| Price/Sales (x): | n/a |
| Price/Book (x): | 2.48 |
| Price/Cash Flow (x): | n/a |
| Quick Ratio (x): | 9.93 |
|---|---|
| Current Ratio (x): | 9.93 |
| LT Debt/Equity (x): | 0.00 |
| Total Debt/Equity (x): | 0.00 |
